“I don’t believe we can maximize our impact on ovarian cancer without embracing opportunities in other gynecologic cancers.” Dr. David Huntsman David Huntsman, MD, FRCPC, FCCMG, understands the field of … Continued
Ie-Ming Shih, MD, PhD is on a quest to better understand the human condition. He is a pathologist who studies human tissue to learn more about the origins of ovarian … Continued
OCRA is now accepting nominations for the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research. The deadline to submit a nomination is 5:00pm ET on October 31, 2022. About the … Continued
A recent study partly funded by OCRA, and published in the Journal of Clinical Oncology, has shown that frequent aspirin use (defined as more than six times per week for … Continued
A recent study published in Nature Cancer talks about harnessing the power of machine learning to help predict prognosis and response to treatment for those with high-grade serous ovarian cancer … Continued
Targeting a specific oncogene associated with the most common type of ovarian cancer may help increase a patient’s immune response to tumors, according to recent findings from researchers at The … Continued
Recent OCRA-funded research has resulted in the creation of a new bioinformatics tool that holds potential for predicting the best treatment combinations for cancer patients. Bioinformatics is a scientific discipline … Continued
Dr. Sandra Cascio of Magee-Womens Research Institute is a 2021 recipient of OCRA’s Early Career Investigative Grant. With her project, “EGFL6 as a New Regulator of Myeloid Cell Expansion and … Continued
Dr. Martin Cannon, of University of Arkansas for Medical Sciences (UAMS), is a 2021 recipient of OCRA’s Collaborative Research Development Grant. With his project, “Understanding and Targeting Myeloid Populations in … Continued
The following is a press release from Ovarian Cancer Research Alliance and Cancer Research Institute: NEW YORK, May 11, 2022 — The Cancer Research Institute (CRI) and Ovarian Cancer Research … Continued
Many exciting updates about progress against ovarian cancer were presented at this year’s Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer — the largest meeting of gynecologic cancer experts … Continued
The interaction between two partner proteins may promote the growth of the most common ovarian cancer subtype, according to recent findings from OCRA-funded researchers at University of Pennsylvania and Cedars-Sinai … Continued
Get email updates about research news, action alerts, and ways to join the fight.
